{
  "doc": {
    "accession": "0001193125-23-194715",
    "filingType": "8-K",
    "filedDate": "2023-08-07",
    "companyName": "Alnylam Pharmaceuticals, Inc.",
    "cik": "0001178670"
  },
  "event": {
    "kind": "Collaboration",
    "secItem": "Item 1.01",
    "headline": "Alnylam Announces Strategic Collaboration with Roche",
    "summary": "Alnylam entered into a global collaboration with Roche to develop and commercialize zilebesiran.",
    "totalValueUSD": 2700000000,
    "effectiveDate": "2023-07-31"
  },
  "partnership": {
    "partnerA": "Alnylam Pharmaceuticals, Inc.",
    "partnerB": "Roche Holding AG",
    "scope": "Co-development and commercialization of zilebesiran for hypertension",
    "territory": "Worldwide",
    "upfrontPaymentUSD": 310000000,
    "milestonesUSD": 2700000000
  },
  "provenance": {
    "documents": [
      {
        "role": "primary_filing",
        "filename": "d448801d8k.htm",
        "sourceUrl": "https://www.sec.gov/Archives/edgar/data/1178670/000119312523194715/d448801d8k.htm",
        "sha256": "..."
      },
      {
        "role": "press_release",
        "filename": "ex99-1.htm",
        "sourceUrl": "https://www.sec.gov/Archives/edgar/data/1178670/000119312523194715/d448801dex991.htm",
        "sha256": "..."
      }
    ]
  },
  "evidence": [
    {
      "field": "event.kind",
      "sourceFile": "chunk_0001.txt",
      "sourceUrl": "https://www.sec.gov/Archives/edgar/data/1178670/000119312523194715/d448801d8k.htm",
      "selector": "chunk:chunk_0001",
      "snippet": "Under Item 1.01, Alnylam entered into a collaboration agreement with Roche..."
    },
    {
      "field": "partnership.upfrontPaymentUSD",
      "sourceFile": "chunk_0002.txt",
      "sourceUrl": "https://www.sec.gov/Archives/edgar/data/1178670/000119312523194715/d448801dex991.htm",
      "selector": "chunk:chunk_0002",
      "snippet": "Roche will pay Alnylam $310 million upfront..."
    }
  ]
}
